COVID-19 vaccines given to children last fall helped keep many out of emergency rooms and urgent care, new data shows.

Men and women with emphysema benefit from endoscopic lung volume reduction (ELVR), but women may have better symptom response and QoL.

The FDA has approved Exdensur for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in patients aged 12 and older.

The FDA has approved an oral pellet formulation of Orladeyo® to prevent attacks of hereditary angioedema in pediatric patients.

About 9% of patients with inborn errors of immunity/primary immune disorders developed cancer, especially B-NHL, a European study found.

The American Academy of Pediatrics updated its COVID-19 vaccination recommendations for preventing severe disease in children.

The US Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines.

Adult patients with CAP in a low-resource setting who were treated with adjunctive low-dose glucocorticoids had a lower risk of death.

Higher lactate concentrations and hypotension are independently linked to increased mortality risk in critically ill adults with COVID-19.

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

South Carolina health officials say a measles outbreak is growing amid holiday travel and low vaccination rates.